An interventional study of magnetic resonance imaging in Fibrosis and Cirrhosis, sponsored by Seoul National University Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-12-17.
Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Diagnostic
The purpose of this study is to assess degree of hepatic fibrosis using multiparametric MRI for investigating difference between normal or early fibrosis and advanced fibrosis.
In patients with liver parenchymal disease or normal liver parenchyma who are scheduled to undergo either liver resection or liver biopsy are included.
Referred patients undergo multiparametric MRI including perfusion, diffusion, elastography and fat quantification before surgery or biopsy.
The pathophysiologic changes are evaluated using multiparametric MRI, and compared between normal/early fibrosis and advanced fibrosis.
3,255 studies on the registry are indexed under Fibrosis; 465 are open to participants now.
This study's enrollment of 69 is above the median of 50 across 2,130 interventional studies indexed under Fibrosis.
Browse Fibrosis studies →Seoul National University Hospital is the lead sponsor of 1,860 studies on the registry; 275 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:
Exclusion Criteria: Patients who have at least one of followings are excluded.
multiparametric MRI including perfusion, diffusion, MR fat quantification and MR elastography
Procedure: magnetic resonance imaging
multiparametric MRI as follows: 1. diffusion weighted imaging using multiple b-values 2. Fat quantification sequence 3. perfusion MRI using ECCM agent 4. MR elastography ------------------------------------ 5. routine MRI using hepatocyte specific agent (optional in patients with focal liver lesion)
Also known as: MRI
difference of portal flow between no or early hepatic fibrosis and advanced hepatic fibrosis
Time frame: in three years
difference of arterial flow between no or early hepatic fibrosis and advanced hepatic fibrosis
Time frame: in three years
difference of liver stiffness value between no or early hepatic fibrosis and advanced fibrosis
Time frame: in three years
monitoring of transient dyspnea after contrast media injection
Time frame: in three years
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Hospital